MARATTO

review · Cureus

Liberal Versus Restrictive Transfusion in Acute Brain Injury: A Systematic Review and Meta-Analysis

20251 citationOpen accessUniversity of Bamenda

In plain language

This systematic review and meta-analysis assessed the safety and efficacy of liberal versus restrictive blood transfusion strategies in patients suffering from acute brain injury, including traumatic brain injury, subarachnoid haemorrhage, and intracranial haemorrhage. Researchers synthesised data from six randomised controlled trials involving 2,645 patients. The primary analysis found no statistically significant difference between a liberal transfusion threshold of ten grams per decilitre or less and a restrictive threshold of eight grams per decilitre or less regarding unfavourable neurological outcomes at six months, mortality, acute respiratory distress syndrome, or infections. Although secondary sensitivity analyses indicated a potential neurological benefit with liberal transfusion when altering the analytical model or excluding one trial, the primary findings suggest that overall outcomes do not substantially differ. Consequently, adopting a restrictive transfusion approach remains a reasonable practice to preserve scarce blood supplies.

Key takeaways

  • A meta-analysis of six randomised controlled trials found no statistically significant difference in outcomes between liberal and restrictive transfusion strategies for acute brain injury.
  • The primary analysis demonstrated that unfavourable neurological outcomes at six months occurred in 55.7 percent of liberal strategy patients compared to 61.4 percent of restrictive strategy patients.
  • Sensitivity analyses suggested a potential benefit for liberal transfusions in reducing poor neurological outcomes when adjusting the statistical model or excluding a specific study.
  • A restrictive transfusion strategy appears reasonable to help conserve scarce blood supplies until clearer evidence is established.

Why it matters

Determining blood transfusion thresholds for patients with acute brain injury is vital for clinical care. Higher thresholds theoretically deliver more oxygen to injured brain tissue but deplete limited blood supplies and carry risks of transfusion reactions. Demonstrating that restrictive strategies yield broadly similar outcomes helps clinicians and healthcare systems optimize blood utilisation without compromising general safety.

Commercialisation angle

The findings are relevant to critical care clinicians, hospital blood banks, and healthcare policy makers developing clinical practice guidelines for neurocritical care. As this research synthesises existing clinical trials, the insights can be directly applied to hospital protocols to support blood conservation programmes, though the abstract does not indicate any commercial product or technology development pathway.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

Oxygen is critical for neurological function and survival, particularly in acute brain injury. Although transfusion at higher thresholds theoretically provides improved oxygen delivery to neurons, there is an associated risk of allogeneic reactions and increased utilization of limited blood resources. Conversely, although a lower threshold conserves resources, it may increase the risk of neuronal oxygen deprivation. The optimal transfusion strategy for patients with acute brain injury remains unclear. This systematic review and meta-analysis aimed to compare the efficacy and safety of liberal (hemoglobin threshold ≤10 g/dL) versus restrictive (≤8 g/dL) transfusion strategies in patients with acute brain injury (traumatic brain injury (TBI), subarachnoid hemorrhage, or intracranial hemorrhage), synthesizing evidence from randomized controlled trials (RCTs). We searched the PubMed, Excerpta Medica database (Embase), and the Cochrane Central Register of Controlled Trials (CENTRAL) databases to identify RCTs comparing restrictive and liberal transfusion strategies in patients with acute brain injury. Eligible trials reported outcomes including (1) unfavorable neurological outcomes defined as a score ≤5 on the Glasgow Outcome Scale Extended (GOSE) at six months, (2) mortality, (3) acute respiratory distress syndrome (ARDS), and (4) infections. Statistical heterogeneity was assessed using I² statistics. To account for statistical heterogeneity, a random-effects model was used to analyze all outcomes. We included six RCTs comprising 2,645 patients, of whom 1,303 (49.2%) were randomized to a liberal transfusion strategy. A reduction in unfavorable neurological endpoints (55.7% vs. 61.4%; risk ratios (RR) 0.92; 95% CI 0.84-1.01) was observed in the liberal group, although this difference was not statistically significant. In sensitivity analyses of unfavorable neurologic outcomes, statistical significance was achieved by removing a single paper (54.7% vs. 61.6%; RR 0.89; 95% CI 0.84-0.95) or by employing a fixed-effects model (RR 0.91; 95% CI 0.85-0.97). This meta-analysis suggests that there is no substantial difference in outcomes between a liberal and a restrictive transfusion strategy in patients with acute brain injury. While our primary analysis showed no statistically significant difference between strategies, sensitivity analyses suggested a potential benefit of liberal transfusion in reducing unfavorable neurologic outcomes. However, given the non-significant primary results and the importance of blood conservation, a restrictive strategy may be reasonable until further evidence emerges.

Research topics

  • Blood transfusion and management
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Cardiac Arrest and Resuscitation

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.7759/cureus.83847

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.